Items where Funder is Breast Cancer UK Ltd.

Hutchinson, SA, Websdale, A, Cioccoloni, G orcid.org/0000-0003-0102-9182 et al. (15 more authors) (2021) Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer. Oncogene, 40. pp. 2872-2883. ISSN 0950-9232

Solheim, S, Hutchinson, SA, Lundanes, E et al. (3 more authors) (2019) Fast liquid chromatography-mass spectrometry reveals side chain oxysterol heterogeneity in breast cancer tumour samples. Journal of Steroid Biochemistry and Molecular Biology, 192. 105309. ISSN 0960-0760

Leif, F, Pfänder, P, Murtuza Baker, S et al. (8 more authors) (2019) Nuclear receptor profiling predicts chemical disruptors as risk factors for developing breast cancer. In: Endocrine Abstracts (2019). Society for Endocrinology BES 2019, 11-13 Nov 2019, Brighton, UK. Society for Endicronology .